Sysmex XE-2100C Automated Hematology System; an automated differential cell counter; Sysmex Corp...

FDA Device Recall #Z-0256-2013 — Class II — June 1, 2012

Recall Summary

Recall Number Z-0256-2013
Classification Class II — Moderate risk
Date Initiated June 1, 2012
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Sysmex America, Inc.
Location Mundelein, IL
Product Type Devices
Quantity 69 units

Product Description

Sysmex XE-2100C Automated Hematology System; an automated differential cell counter; Sysmex Corporation, Kobe, Japan; Sysmex America, One Nelson C. White Parkway, Mundelein, IL 60060; catalog #053-2311-4 The Sysmex XE-2100C is an automated hematology analyzer for in vitro diagnostic use in screening patient populations found in clinical laboratories.

Reason for Recall

There is a variation of reticulocyte counts between XE Series (XE-2100, XE-5000) and XT-Series (XT-2000i, XT-4000i) hematology analyzers that may result in a retic counts that are an average of 21% lower on the XE-Series because of a low bias.

Distribution Pattern

Nationwide distribution: USA including Puerto Rico.

Lot / Code Information

catalog ##053-2311-4, all serial numbers

Other Recalls from Sysmex America, Inc.

Recall # Classification Product Date
Z-1136-2026 Class II TS-10/TS-10H Tube Sorter, automatic sorting sys... Dec 15, 2025
Z-1113-2025 Class II Sysmex PS-10 Sample Preparation System with sof... Jan 6, 2025
Z-2687-2020 Class II Sysmex PS-10 Sample Preparation System Catalog... Jul 6, 2020
Z-1703-2020 Class II The CF-70 instrument (product code: LXG; Regula... Mar 9, 2020
Z-1717-2020 Class II Sysmex CV-11 Sample Unit, an integrated modular... Jan 21, 2020

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.